Study of the prevalence of neuropsychological deficits in patients recovered from COVID-19 associated with post-intensive care syndrome
- Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
- Total publications:0 publications
Grant number: 20/07957-2
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)Principal Investigator
Antonio de Pádua SerafimResearch Location
BrazilLead Research Institution
Diretoria de Pós-Graduação e Pesquisa. Universidade Metodista de São Paulo (UMESP). Instituto Metodista de Ensino Superior (IMS). São Bernardo do Campo , SP, BrazilResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Post acute and long term health consequences
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
It is estimated that approximately one third or more of ICU survivors develop continuous and persistent cognitive impairment. As for patients with acute respiratory syndromes such as Covid-19, the prevalence of persistent cognitive impairment is even higher and can reach 78% in 1 year and 25% in 6 years. The literature has treated this phase of post-intensive care syndrome from English Post-intensive care syndrome (PICS), which describes, impairment of psychological health (emotional and cognitive) and physical function of patients who required ICU care. The aim of this study is to evaluate neuropsychological aspects in patients recovered from COVID-19. Method: Observational study that will use a digital platform containing a brief questionnaire of sociodemographic data and information on Covid-19 contamination and a neuropsychological battery with measures of attention, memory and executive functions, in addition to depressive and anxious aspects. It is intended to evaluate a sample of more than 500 participants for the composition of three groups: Light, Moderate and Serious Symptoms (treated in the ICU). The results of this study are expected to provide a cognitive overview of the sample to support the development of neuropsychological rehabilitation programs for patients with Covid-19 cognitive sequelae. (AU)